Background: Evolutionary conserved Bax inhibitor-1 (BI-1) protects against ER stress-mediated apoptosis.
Results: We identified a Ca2+-permeable channel pore in the C terminus of BI-1. Critical pore properties are an α-helical structure and two aspartate residues conserved among animals, but not among plants and yeast.
Conclusion: C-terminal domain of BI-1 harbors a Ca2+-permeable channel pore.
Significance: BI-1 has Ca2+ channel properties likely relevant for its function in ER stress and apoptosis.
Keywords: Calcium, Calcium Channels, Calcium Signaling, Evolution, Peptides, Calcium, Calcium Channels, Evolution, Peptides
Abstract
Bax inhibitor-1 (BI-1) is a multitransmembrane domain-spanning endoplasmic reticulum (ER)-located protein that is evolutionarily conserved and protects against apoptosis and ER stress. Furthermore, BI-1 is proposed to modulate ER Ca2+ homeostasis by acting as a Ca2+-leak channel. Based on experimental determination of the BI-1 topology, we propose that its C terminus forms a Ca2+ pore responsible for its Ca2+-leak properties. We utilized a set of C-terminal peptides to screen for Ca2+ leak activity in unidirectional 45Ca2+-flux experiments and identified an α-helical 20-amino acid peptide causing Ca2+ leak from the ER. The Ca2+ leak was independent of endogenous ER Ca2+-release channels or other Ca2+-leak mechanisms, namely translocons and presenilins. The Ca2+-permeating property of the peptide was confirmed in lipid-bilayer experiments. Using mutant peptides, we identified critical residues responsible for the Ca2+-leak properties of this BI-1 peptide, including a series of critical negatively charged aspartate residues. Using peptides corresponding to the equivalent BI-1 domain from various organisms, we found that the Ca2+-leak properties were conserved among animal, but not plant and yeast orthologs. By mutating one of the critical aspartate residues in the proposed Ca2+-channel pore in full-length BI-1, we found that Asp-213 was essential for BI-1-dependent ER Ca2+ leak. Thus, we elucidated residues critically important for BI-1-mediated Ca2+ leak and its potential channel pore. Remarkably, one of these residues was not conserved among plant and yeast BI-1 orthologs, indicating that the ER Ca2+-leak properties of BI-1 are an added function during evolution.
Introduction
The endoplasmic reticulum (ER)3 is the main intracellular Ca2+ store and it plays a central role in intracellular Ca2+ homeostasis and dynamics (1). The Ca2+ concentration in the ER ([Ca2+]ER) is dynamically regulated by Ca2+-uptake pumps of the sarco/endoplasmic-reticulum Ca2+-ATPase family, intraluminal Ca2+-binding proteins, like calreticulin and calnexin, and Ca2+-release channels, like inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) (2). In a resting cell, the steady-state [Ca2+]ER is ultimately determined by the equilibrium between the active uptake and the basal or passive leak of Ca2+ from the ER. The control of [Ca2+]ER requires a tight handling of these mechanisms, because an increase in [Ca2+]ER renders cells hypersensitive toward agonist-induced Ca2+ signaling, whereas a decrease in [Ca2+]ER may provoke ER stress and the activation of the unfolded protein response (3, 4). The passive Ca2+ leak has been one of the most enigmatic paradigms in Ca2+ signaling, given the poor understanding of the molecular mechanisms and candidates responsible for the passive Ca2+ leak (5). Recent work from the laboratories of Reed and Chae (6, 7) demonstrated that Bax inhibitor-1 (BI-1) affects passive Ca2+ leak from the ER. BI-1 has originally been identified as a suppressor of Bax-induced cell death in yeast (8) and was shown to affect the passive Ca2+ leak from the ER (9, 10). BI-1 seems to be strongly evolutionarily conserved and BI-1 orthologs from plants can substitute for mammalian BI-1 in regard to its anti-apoptotic function (11). Besides this, other diverse functions of BI-1 have been described. BI-1 is a negative regulator of the ER-stress sensor IRE1α (12), it interacts with G-actin and increases actin polymerization (13), enhances cancer metastasis by altering glucose metabolism and by activating a sodium-hydrogen exchanger (14), and it reduces production of reactive oxygen species through direct interaction with NADPH-P450 reductase (15), a member of the microsomal monooxygenase system.
Recently, the role of BI-1 in Ca2+ signaling has been further explored. The effect of BI-1 on cell death seems to involve changes in the amount of Ca2+ that is releasable from intracellular stores (reviewed in Ref. 16). BI-1 physically interacts with Bcl-2 and Bcl-xL in the membrane of the ER (9), and may modulate the ER Ca2+ homeostasis downstream of Bcl-xL (6). BI-1 overexpression led to a decrease in [Ca2+]ER, whereas BI-1−/− cells displayed increased [Ca2+]ER (9). Bcl-xL overexpression led to a decrease in [Ca2+]ER as well, but only in the presence of BI-1. Furthermore, BI-1 increased the permeability of ER membranes for Ca2+ and mediated, in a pH-dependent manner, a Ca2+ release from proteoliposomes reconstituted with purified BI-1 (7). The C-terminal region containing a lysine-rich motif (EKDKKKEKK) has been identified as a pH sensor of the BI-1 Ca2+ channel (7), being essential for tetramerization and the Ca2+-release properties of BI-1.
Given the central role of the ER in controlling cell-survival and cell-death responses (17–23), it is reasonable to assume that the activity of BI-1 as a Ca2+ channel can be an important determinant in these processes. However, the exact topology of BI-1 in the ER membrane and the position of the Ca2+ pore are still unresolved. In this work, we present data on the topology of BI-1 in the ER membrane and results of screening a set of peptides representing the C-terminal hydrophobic part of BI-1 for their potential Ca2+-leak activity in unidirectional Ca2+ fluxes. We identified an α-helical 20-amino acid peptide that is responsible for the Ca2+ leak from the ER independently of other endogenous ER Ca2+-release channels and Ca2+-leak mechanisms, such as IP3Rs, RyRs, translocons, and presenilins. The Ca2+-flux properties of the peptide were confirmed in lipid bilayer experiments. Using mutant peptides, we identified critical negatively charged aspartate residues contributing to the potential Ca2+-channel pore and we show that Ca2+ release properties of the BI-1 peptide require its hydrophobic and α-helical structure. Using peptides corresponding to BI-1 from other organisms, we found that Ca2+-transport properties are conserved among animal orthologs, but not in plant and yeast orthologs. Hence, this study identified a peptide derived from the C-terminal part of BI-1 that may be involved in the formation of a Ca2+-channel pore. Importantly, we found that replacing one of the critical aspartate residues in the proposed Ca2+-channel pore in the full-length BI-1 was sufficient to abolish the BI-1-mediated Ca2+ leak.
EXPERIMENTAL PROCEDURES
Cell Culture
Mouse embryonic fibroblasts (MEF cells) were cultured at 37 °C in a 9% CO2 incubator in DMEM/Ham's F-12 medium supplemented with 10% fetal calf serum, 3.8 mm l-glutamine, 85 units ml−1 of penicillin, and 85 μg ml−1 of streptomycin. All media were obtained from Invitrogen. DT40 cells were cultured as previously described (24).
For the 45Ca2+ fluxes, MEF cells were seeded in 12-well clusters (Costar, MA, 4 cm2) at a density of ∼104 to 2 × 104 cells cm−2. Experiments were carried out with confluent monolayers of cells (7.5 × 104 cells cm−2) between the 5th and 7th day after plating. Lvec control cells were seeded in 12-well clusters (Greiner) at a density of 4 × 104 cells/well, whereas IP3R1-overexpressing L15 cells were seeded at a density of 6 × 104 cells per well. These fibroblast L cell lines have been previously created and characterized (25, 26). Experiments were carried out on confluent cell monolayers between the 6th and 8th day after seeding.
Human cervical carcinoma cells HeLa T1 cells were cultured in DMEM containing 10% FBS, 2% Glutamax, 100 units ml−1 of penicillin, and 100 units ml−1 of streptomycin (Invitrogen). For studies of full-length BI-1, 3 × 104 cells were seeded on 2-chamber borosilicate slides (Nunc) 1 day before transfection.
Peptides and Chemical Reagents
All synthetic peptides were obtained from ThermoFisher Scientific (Ulm, Germany) at a purity of more than 90%. The identity of the peptides was confirmed via mass spectrometry and the purifications were performed via HPLC. 2-Aminoethoxydiphenyl borate, ryanodine, and anisomycin were obtained from Sigma.
Topology Assay
Neuro2A cells were transfected with hemagglutinin-tagged (HA) BI-1 (HA-BI-1), BI-1-HA, ERp44-HA, or empty vector in 10-cm cell culture dishes at a confluence of 80–90% using the Attractene Transfection Reagent (Qiagen) according to the manufacturer's protocol. 24 h later, cells were harvested and the cell suspension was divided into three fractions. These fractions of suspended cells were permeabilized with either 20 μm digitonin or 0.1% Triton X-100 in PBS for 30 min on a rocking platform at room temperature or were kept unpermeabilized in PBS. For incubation with Triton X-100, cells were first fixed with 4% paraformaldehyde for 10 min at 37 °C. After permeabilization, cells were washed twice with either PBS containing 2 μm digitonin or 0.01% Triton X-100, or in PBS alone, and stained with Alexa Fluor 488-conjugated anti-HA tag antibody (Cell Signaling Technology) diluted 1:20 in wash buffer for 30 min on a shaker protected from light. After two wash steps cells were transferred to FACS tubes and analyzed on a FACS Calibur (BD Biosciences).
45Ca2+ Fluxes
Unidirectional 45Ca2+ flux experiments were performed essentially as previously described (27–29). The 12-well clusters were fixed on a thermostated plate at 25 °C on a mechanical shaker. The culture medium was aspirated, and the cells were permeabilized by incubating them for 10 min in a solution containing 120 mm KCl, 30 mm imidazole-HCl (pH 6.8), 2 mm MgCl2, 1 mm ATP, 1 mm EGTA, and 20 μg ml−1 of saponin. The non-mitochondrial Ca2+ stores were then loaded for 45 min in 120 mm KCl, 30 mm imidazole-HCl (pH 6.8), 5 mm MgCl2, 5 mm ATP, 0.44 mm EGTA, 10 mm NaN3, and 150 nm free 45Ca2+ (28 μCi ml−1). Then, 1 ml of efflux medium containing 120 mm KCl, 30 mm imidazole-HCl (pH 6.8), and 1 mm EGTA was added and replaced every 2 min. The indicated [IP3] or 10 μm Ca2+ ionophore A23187 were added for 2 min, after 2, 10, or 20 min of efflux. At the end of the experiment, all 45Ca2+ remaining in the stores was released by incubation with 1 ml of a 2% (w/v) SDS solution for 30 min. Concentration-response curves were fitted using Origin 7.0 (Northampton, MA) software using the Hill equation.
Mag-Fluo4 Measurements in DT40 and TKO Cells
These experiments were performed as described (30, 31). Briefly, DT40 and triple IP3R-knock out (TKO) cells were grown to a density of about 1 × 106 cells/ml−1 and loaded with Mag-Fluo4 AM (20 μm) for 60 min at 20 °C. Cells were permeabilized by incubation with saponin (10 μg·ml−1) for 4 min at 37 °C. After centrifugation, cells were resuspended in Mg2+-free cytosol-like medium (140 mm KCl, 20 mm NaCl, 1 mm EGTA, and 20 mm PIPES, pH 7.0), supplemented with 375 μm CaCl2 and 10 μm carbonyl cyanide p-trifluoromethoxyphenylhydrazone, which inhibits mitochondrial Ca2+ uptake. Cells were dispensed into a 96-well black-walled assay plate pre-coated with poly-l-lysine and centrifuged to spin the permeabilized cells to the bottom of the wells. Cells were incubated with 90 μl of fresh Mg2+-free cytosol-like medium, supplemented with 375 μm CaCl2 and 10 μm carbonyl cyanide p-trifluoromethoxyphenylhydrazone. Mag-Fluo4 signals were measured with FlexStation3 with automated additions (settings: excitation 490 nm, emission 525 nm, reading sensitivity normal (five readings), and photomultiplier tube sensitivity high). At 30 s, 10 μl of 15 mm Mg-ATP (1.5 mm final) was added to initiate Ca2+ uptake. After reaching steady-state store loading, 20 μl of 6 μm thapsigargin (1 μm final) was added and 40 s later, 20 μl of peptides were added at 7× final concentration in the medium. This medium contained a final concentration of 1 μm thapsigargin to block Ca2+ pumps and 10 μm carbonyl cyanide p-trifluoromethoxyphenylhydrazone to block mitochondrial Ca2+ fluxes.
Fura-2 for Measuring Cytosolic [Ca2+]
Thirty thousand HeLa T1 cells were seeded on borosilicate 2-chamber slides (Nunc). The next day, cells were co-transfected with 1.5 μl of FuGENE 6 (Roche Diagnostics) and 0.25 μg of pcDNA3.1-mCherry and 0.25 μg of pcDNA3.1 (mock), pcDNA3.1 myc-BI-1, or myc-BI-1-D213R. Thirty-six hours post-transfection, cells were loaded with 1.25 μm Fura-2-AM (Invitrogen) diluted in Krebs-Ringer solution (11 mm HEPES, 125 mm NaCl, 6 mm KCl, 3 mm MgCl2, 13 mm glucose, pH 7.5) and prepared for microscopy. For recording cytosolic [Ca2+], we used a Zeiss AxioObserver.Z1 microscope with a Fluor ×20/0.75 objective, Sutter Lambda DG-4 monochromator and filter sets 21 and 62 (Zeiss) for Fura-2 and mCherry, respectively. Images were recorded with an AxioCamHsM camera in the AxioVision version 4.6 software physiology module. mCherry-positive cells were preselected for the recordings, and Fura-2 fluorescence was recorded every 2 s. For the chelation of Ca2+, we used 3 mm 1,2-bis(2-aminophenoxyl)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) (Invitrogen), which rapidly chelates the extracellular Ca2+. Release of Ca2+ from intracellular stores was induced with 4 μm thapsigargin, which specifically inhibits the activity of sarco/endoplasmic reticulum Ca2+-ATPase pumps at low micromolar concentrations. Ca2+ traces were calibrated by incubating the cells for 10 min, first with Krebs-Ringer solution containing 50 mm EGTA and 2 μm ionomycin (LC Labs), and then with 250 mm CaCl2 and 2 μm ionomycin. Traces were then converted into [Ca2+] using the formula,
![]() |
where Kd = 225 nm (32).
Western Blot
Cells from 2-chamber slides were trypsinized and lysed in RIPA buffer (20 mm Tris, 150 mm NaCl, 1.5 mm MgCl2, 0.5 mm DTT, and 1% Triton X-100, pH 7.5) with 1× protease inhibitor cocktail (Roche Diagnostics). Protein concentration was determined with the Bradford method and 10 μg of total protein lysate was prepared in urea sample buffer (200 mm Tris, pH 6.8, 5% SDS, 0.1 mm EDTA, 8 m urea, 0.1% bromphenol blue, and 100 mm DTT). Samples were heated for 10 min at 37 °C before loading on a precasted NuPAGE 4–12% BisTris gel in MOPS buffer (Invitrogen). Proteins were transferred in running buffer (25 mm Tris, 190 mm glycine, 10% methanol) on a PVDF membrane. The membrane was blocked in TBS (10 mm Tris, 150 mm NaCl, pH 7.5) supplemented with 5% milk powder and 0.1% Tween 20. Expression of the Myc-BI-1 fusion protein was detected using an anti-Myc antibody (Sigma). The membrane was stripped with a mild stripping buffer (ThermoFisher Scientific) and reblotted with an antibody against glyceraldehyde-3-phosphate dehydrogenase (Sigma) as a loading control.
Electrophysiological Recordings from Planar Lipid Bilayers
Planar lipid bilayer were formed (3:1 mixture of phosphatidylethanolamine/phosphatidylserine lipids (Avanti Polar Lipids) dissolved in decane) on a 200-μm diameter aperture separating cis and trans chambers containing: (cis) 95 mm Tris-OH, 200 mm HEPES (pH 7.3, ∼300 mosmol; [Ca2+]free = 10 nm) and (trans) 50 mm Ba(OH)2, 55 mm HEPES (pH 7.3, ∼285 mosmol) solutions, respectively. Peptides dissolved in dimethyl sulfoxide were added to the cis chamber at gradually increasing concentrations, and stirred continuously between the periods of membrane current recordings that were done using the Axopatch 1 amplifier and pClamp6 software (Axon Instruments). The cis chamber was grounded. Experiments were done at room temperature. Holding potential (Vh) was 0 mV for all experiments except when indicated. Off-line current-trace filtering (500 Hz), calculations of the mean current passing by lipid bilayer (Imean), and histogram calculations and statistics analysis were done using pClamp10 and OriginPro 7.5 (OriginLab) software.
RESULTS
The Seventh Transmembrane Domain of BI-1 Resembles a Pore
The attempt to attribute a Ca2+-channel function to BI-1 is hampered by unresolved exact topology of the BI-1 in the ER membrane. We have previously shown that the C terminus of BI-1 resides in the cytosol (16), which results in two different models (Fig. 1A). In model A, which is supported by TMpred, the N terminus is located in the ER lumen. In model B, which is bioinformatically supported by TMHMM, the N terminus is cytosolic and the semi-hydrophobic seventh transmembrane domain, which bears some homology to the loop domain of the voltage-gated sodium channel SCN5A, would dip into the membrane, creating a loop domain (Fig. 1B). Unfortunately, it is not possible to use the enhanced green fluorescent protein protease-protection assay used previously (16) to distinguish between these two models, because the addition of an N-terminal enhanced green fluorescent protein alters the function of BI-1,4 indicating that the bulky enhanced green fluorescent protein moiety at the N terminus might alter the topology or intracellular localization of BI-1.
FIGURE 1.
BI-1 contains six transmembrane domains and a C-terminal loop domain. A, bioinformatical prediction of the topology of BI-1 in the ER membrane according to TMpred and TMHMM. The arrowhead in model B indicates the beginning of the C-terminal region of BI-1, including the CTP1, CTP2, and pH-sensor domains. B, amino acid-sequence of the BI-1 C terminus according to model B, indicating CTP1, CTP2, a potential loop domain with homology to SCN5A (indicated in blue), and the C terminus according to model A (indicated in red). Mapped interacting sites are indicated. C, selective permeabilization of the plasma membrane allows staining of HA-BI-1 and BI-1-HA but not of luminal ERp44. N2a cells were transiently transfected with the indicated plasmids and permeabilized with digitonin, which only permeabilizes the plasma membrane, or Triton X-100, which permeabilizes all cellular membranes. Cells were then stained with an FITC-labeled anti-HA antibody and fluorescence was quantitated by flow cytometry as shown in the representative plots. Bar graphs represent mean ± S.E. of six pooled independent experiments done in triplicates.
We therefore modified the assay by using cells overexpressing proteins tagged with the very short HA tag and selective membrane permeabilization. Digitonin makes epitopes in the cytosol, but not in the ER lumen, accessible to fluorescent antibodies, which can be quantified by flow cytometry. Treatment with Triton X-100, in contrast, permeabilizes all membranes and leads to staining of both luminal and cytosolic epitopes. We overexpressed HA-BI-1 or BI-1-HA in Neuro2a cells and used the luminal endoplasmic-reticulum protein (ERp) 44-HA as negative control (Fig. 1C). Both HA-BI-1 and BI-1-HA resulted in a similar increase in immunoreactivity after digitonin treatment, whereas ERp44 staining never exceeded the level apparent in cells transfected with an empty vector. Permeabilization with Triton X-100, on the other hand, dramatically increased HA immunoreactivity in ERp44-HA-transfected cells and had no further significant effect on HA-BI-1 and BI-1-HA. These results favor model B, although it cannot be completely excluded that the fusion with HA itself may alter the topology of BI-1.
A C-terminal Peptide Representing the Putative Pore Domain of BI-1 Causes Ca2+ Release from the ER Ca2+ Stores
The model supported by the experiments in Fig. 1 suggested a possibility of the presence of a pore domain right before the proposed C-terminal domains of BI-1 interacting with IRE1α (12), G-actin (13), and NADPH-P450 reductase (15), and forming the pH-sensor domain (7). Hence, we developed a set of two overlapping peptides named CTP1 (HGDQDYIWHCIDLFLDFITV) and CTP2 (CIDLFLDFITVFRKLMMILAMNEKD) covering the residues following the 6th transmembrane domain, but excluding the pH-sensor domain of BI-1 (Fig. 1B).
The Ca2+-flux properties of these peptides were examined in unidirectional 45Ca2+-flux assays in saponin-permeabilized MEF cells. This assay provides an accurate assessment of Ca2+-flux properties of channels under unidirectional conditions (28, 29, 33, 34). In short, after permeabilization of the MEF cells, 45Ca2+ was loaded to a steady-state in the non-mitochondrial Ca2+ stores, which correspond largely to the ER. After irreversible inhibition of the Ca2+ pumps by thapsigargin, the Ca2+ leak from these stores can be measured under unidirectional conditions. The Ca2+ content of the stores gradually decreased with time under these conditions (Fig. 2A). The released Ca2+ divided by the amount of Ca2+ that was present in the store at that time (= fractional loss), was determined and plotted (Fig. 2B). This analysis provides an accurate quantitative analysis of the Ca2+ leak from the ER. In control conditions, the Ca2+ content of the stores gradually decreased (Fig. 2A, vehicle), whereas addition of 60 μm CTP1, but not of CTP2, accelerated the decrease in store Ca2+ content (Fig. 2A) and resulted in an increased Ca2+ leak from the ER (Fig. 2B). The concentration-dependent effects of CTP1 on the Ca2+ leak were obtained by adding different concentrations of CTP1 (5, 10, 20, 40, and 80 μm) after 10 min of efflux (Fig. 2C). These effects were normalized for the maximal releasable Ca2+, obtained by the addition of 10 μm A23187, a Ca2+ ionophore. The dose-response curve (Fig. 2D) was fitted by a logistic curve fitting, yielding an EC50 value of about 30 μm and a power (steepness of the curve) of 3. This indicates that CTP1-induced Ca2+ release is highly cooperative, which is compatible with an oligomerization-dependent process and suggests that at least three CTP1 peptides are required to form a functional Ca2+-channel pore.
FIGURE 2.
A peptide derived from the C-terminal end of BI-1 (CTP1), corresponding to amino acids 198–217 induces Ca2+ release from the ER. A, permeabilized MEF cells loaded to steady-state with 45Ca2+ were incubated in Ca2+-free efflux medium and their Ca2+ content, expressed in counts per min (cpm), monitored as a function of time. In the time period indicated by the line, vehicle, CTP1, and CTP2 were added for 8 min. CTP1, but not CTP2, led to a decrease in the Ca2+ content. B, results obtained from the experiment described in A were plotted as “fractional loss” (%/2 min) as a function of time. CTP1, but not vehicle or CTP2, provoked an increase in the fractional loss. C, different concentrations of CTP1 were added during the efflux phase for 6 min. Results were plotted as fractional loss as a function of time. D, CTP1-induced Ca2+ release from 45Ca2+-loaded permeabilized cells was quantified as the difference in fractional loss between 2 min after application of CTP1 and before CTP1, i.e. the fractional loss at 10 min minus the fractional loss at 8 min. Concentration-response curve for CTP1-induced Ca2+ release was obtained from three independent experiments. All results were normalized to the Ca2+ released by the Ca2+ ionophore, A23187, and expressed as % of total A23187-induced Ca2+ release.
CTP1-induced Ca2+ Release Is Independent of the Presence of BI-1, IP3Rs, RyRs, Presenilins, and Translocon
To elucidate whether the Ca2+ release mediated by CTP1 was caused by modulation of BI-1 or other documented Ca2+-release mechanisms, we examined the Ca2+-flux properties of CTP1 in the absence of BI-1, IP3R, RyR, presenilin, and translocon activity. First, we used primary BI-1 knock-out MEF cells and found that the Ca2+ release mediated by CTP1 did not differ between primary wild-type and BI-1−/− MEF cells (Fig. 3A). Second, using inhibitors of IP3Rs (100 μm 2-aminoethoxydiphenyl borate), RyRs (100 μm ryanodine), and the translocon (100 μm anisomycin), we found that the Ca2+-release properties of CTP1 were not affected by these inhibitory compounds (Fig. 3B). Third, a recent study proposed presenilins as important Ca2+-leak channels from the ER (35), although direct modulation of IP3R activity by presenilins may also contribute to the effect (36–38). However, we excluded the contribution of presenilins by examining the Ca2+-release properties of CTP1 in presenilin-1/2 double knock-out MEF cells (Fig. 3C). CTP1 mediated similar increases in the Ca2+ flux from the ER of wild-type and presenilin-1/2 double knock-out MEF cells, indicating that the Ca2+-release properties of CTP1 were not due to modulation or activation of presenilin Ca2+-channel activity. Fourth, the contribution of IP3Rs in mediating CTP1-induced Ca2+ release was further directly assessed by using L15 fibroblasts overexpressing IP3R1 and DT40 TKO cells. By analyzing the CTP1-induced Ca2+ release from the ER of permeabilized fibroblasts either expressing an empty vector (Lvec) or overexpressing IP3R1 (L15), we found that CTP1 mediated similar increases in the Ca2+-leak rate from the ER of control fibroblasts and IP3R1-overexpressing fibroblasts (Fig. 3D). Next, we monitored the (Ca2+)ER by using ER-trapped Mag-Fluo4 in permeabilized TKO cells (Fig. 3E) and TKO cells ectopically overexpressing IP3R1 using an automated Ca2+ assay (Fig. 3F). After loading the ER Ca2+ stores to steady-state by adding ATP for active Ca2+ uptake, an unidirectional Ca2+ leak from the ER was initiated by adding thapsigargin, and was measured by monitoring the ER Ca2+ concentration using the low-affinity Ca2+ dye Mag-Fluo4. Then, CTP1 was added and the change in the Ca2+-leak rate was measured. Consistent with our previous experiments, we found that CTP1 enhanced the Ca2+-leak rate in TKO cells and in TKO cells ectopically expressing IP3R1. These results rule out that the effect of CTP1 is mediated through IP3R Ca2+-release channels. Taken together, these experiments indicate that the mechanism of CTP1-induced Ca2+ release does not involve BI-1 or other documented Ca2+-leak or release mechanisms, like IP3Rs, RyRs, translocon, or presenilins.
FIGURE 3.
CTP1-induced Ca2+ release is independent of BI-1, IP3Rs, RyRs, presenilins, and translocon. A, CTP1-induced Ca2+ release from 45Ca2+-loaded permeabilized wild-type and BI-1−/− MEF cells. CTP1 (40 μm) was added during the efflux as indicated. B, CTP1-induced Ca2+ release from 45Ca2+-loaded permeabilized MEF cells in the presence of inhibitors of the IP3R (100 μm 2-aminoethoxydiphenyl borate (2-APB)), the RyR (100 μm ryanodine), and the translocon (100 μm anisomycin). C, CTP1-induced Ca2+ release from 45Ca2+-loaded permeabilized PS1−/− PS2−/− MEF cells (PS, presenilin). Different concentrations of CTP1 were added during the efflux as indicated. D, CTP1-induced Ca2+ release from 45Ca2+-loaded permeabilized Lvec and IP3R1-overexpressing L15 fibroblasts. E and F, CTP1-induced Ca2+ release from Mag-Fluo4-loaded ER of permeabilized DT40 TKO cells and TKO cells ectopically expressing IP3R1. The MagFluo4 signal monitored over time is related to the [Ca2+]ER. Ca2+ uptake in the ER is initiated by addition of ATP. After reaching steady-state, thapsigargin was added to follow unidirectional Ca2+ flux from the ER. After 90 s, different concentrations of CTP1 were added. Ionomycin (10 μm) was added to determine the maximal releasable Ca2+. The vehicle (DMSO, dimethyl sulfoxide) was added to determine the passive Ca2+ leak.
Source of CTP1-induced Ca2+ Release Is IP3-sensitive Ca2+ Store
The ER, the main intracellular Ca2+ store, is IP3 sensitive. Hence, we investigated whether depleting the IP3-sensitive Ca2+ store by adding an activating concentration of IP3 would abolish the CTP1-induced Ca2+ release. Importantly, the ability of CTP1 to mediate Ca2+ release was almost completely abolished after depletion of the IP3-sensitive stores (Fig. 4A), indicating that the main source of the CTP1-induced Ca2+ release largely corresponds to the IP3-sensitive store. This was further supported by experiments in which we compared the CTP1-induced Ca2+ release relative to the Ca2+ release induced by a maximal concentration (50 μm) of IP3 (Fig. 4B). This analysis showed that the maximal amount of releasable Ca2+ by a saturating concentration of CTP1 (80 μm) was >80% of the maximal amount of releasable Ca2+ by 50 μm IP3.
FIGURE 4.
CTP1-induced Ca2+ release originates from the IP3-sensitive store. A, CTP1-induced Ca2+ release from 45Ca2+-loaded permeabilized MEF cells was measured without (■) and with (●) preincubation of a supramaximal concentration of IP3 (50 μm). B, CTP1-induced Ca2+ release, provoked by different concentrations of CTP1, was quantified relative to a supramaximal concentration of IP3 (50 μm). The maximal CTP1-induced Ca2+ release amounted to about 80% of the Ca2+ release provoked by a saturating concentration of IP3.
Ca2+-flux Properties of CTP1 Depend on Its α-Helical Structure and Hydrophobic Residues Clustered in the Peptide
First, we tested whether shorter fragments of CTP1 were able to promote Ca2+ release from the ER (Fig. 5A). Importantly, shortening the CTP1 peptide to smaller fragments, CTP1–1 (YIWHCIDLFLDFITV), CTP1–2 (HGDQDYIWHCIDLFL), and CTP1–3 (YIWHCIDLFL), completely abolished the Ca2+-release properties of CTP1, indicating that the entire CTP1 sequence conveys its functional activity.
FIGURE 5.
CTP1-induced Ca2+ release depends on hydrophobic residues Leu-210 and Phe-211 and on its α-helical properties. A, 45Ca2+ release from permeabilized MEF cells provoked by CTP1 and its truncated forms. Truncated forms of CTP1 did not provoke Ca2+ release from the ER. A representative experiment is shown for 3 independent experiments. B, I-TASSER predictions for CTP1, CTP1-L210A,F211A, CTP1-L210G,F211G, CTP1-C207G,I208G, and CTP1-C207A. C, a plot showing the hydrophobicity score of the CTP1 and the different mutants following the Kyte-Doolittle model (50). Positive values indicate higher hydrophobicity, whereas negative values indicate higher hydrophilicity. D, Ca2+ release from permeabilized MEF cells provoked by CTP1 and mutant forms. A representative experiment is shown for 4 independent experiments. DMSO, dimethyl sulfoxide.
Second, because the predicted secondary structure of the CTP1 peptide displays an α-helical structure (Fig. 5B) with a high hydrophobicity index (second half of CTP1; Fig. 5C), we examined whether the α-helical properties and residues in the hydrophobic stretch were important to promote Ca2+ release (Fig. 5D). Hence, we analyzed the double mutant CTP1-L210A,F211A in the unidirectional 45Ca2+-flux assay. This peptide contains two altered residues in its hydrophobic stretch, but retains its α-helical properties (Fig. 5B). The mutated residues slightly reduce the hydrophobicity score of the second half of CTP1 (Fig. 5C). We found that CTP1-L210A,F211A was not able to induce Ca2+ release. Similar results were found with CTP1-L210G,F211G, which does not possess an α-helical structure (Fig. 5B). To examine whether the α-helical structure of CTP1 is essential for its activity, we created CTP1-C207G,I208G. This peptide contains the essential Leu-210 and Phe-211 residues, but it has a largely altered secondary structure (Fig. 5B). Importantly, this peptide was also not able to promote Ca2+ release. Finally, we developed a control peptide CTP1-C207A, which retains its α-helical structure (Fig. 5B) and its hydrophobicity score (Fig. 5C). As a consequence, this peptide was able to mobilize Ca2+ (Fig. 5D). These data indicate that both residues in the hydrophobic stretch as well as the α-helical structure of CTP1 are essential for its activity. Because the CTP1-L210A,F211A peptide still retains a very high hydrophobicity score, we hypothesize that the Leu-210 and Phe-211 residues may contribute to the oligomerization of the peptide in the membrane, which may be required for CTP1-mediated Ca2+ mobilization from the ER.
CTP1 Displays Channel-like Activity with Permeability for Divalent Cations
Our experiments indicated that CTP1 induces Ca2+-channel activity in ER membranes. Hence, to unequivocally demonstrate that CTP1 is capable to form divalent cation-permeable channel pores, we examined, using Ba2+ as a permeant ion, whether the CTP1 incorporation into planar lipid bilayers would initiate ionic currents transmitted by divalent cations. In a separate set of experiments, either CTP1 or CTP1-L210A,F211A mutant peptides were added at 10 μm increment concentrations to the cis compartment of the bilayer chamber containing a HEPES/Tris solution (free [Ca2+] buffered at 10 nm), whereas the opposite trans chamber contained 50 mm Ba2+. The exposure of the lipid bilayer to CTP1 incrementing from 10 to 30 μm for several minutes for each concentration was without effect, but the further increment to 40 μm resulted in the appearance of a progressively growing Ba2+ current (Fig. 6A, top). The current developed from zero to more than 20 pA within 3–8 min, with longer exposure resulting in disintegration of the bilayer, which prevented careful measurements of the concentration-response relationship at higher concentrations due to a continuously increasing nonstationary current. Such a current was not observed when the CTP1-L210A,F211A mutant peptide was tested at concentrations up to 50 μm (Fig. 6A, bottom). The threshold-like appearance of the CTP1-induced current might be explained by a model where CTP1 accumulation to a critical concentration within a lipid bilayer initiates a chain reaction of formation of ion-conducting channel assemblies. The biophysical properties of the CTP1-forming channels were not studied in detail due to the limited period of observation of clearly distinguishable single-channel openings before appearance of the complicated fluctuating pattern of the CTP1-multichannel activity (Fig. 6B). The current amplitudes analyzed during the first minute of quasi-stationary observation of CTP1 channel activity yielded a broadly distributed shallow peak on a histogram compared with a zero-centered peak for the CTP1-L210A,F211A mutant peptide, which revealed no channel activity for the latter (Fig. 6C). To obtain a meaningful quantitative parameter, a mean current recorded during the first minute of observation of the channel activity in the presence of 40 μm CTP1 was calculated in multiple bilayers and compared with the mean currents recorded in the presence of 50 μm CTP1-L210A,F211A (Fig. 6D), showing a significant ion-transporting capability of the CTP1-forming channels. To confirm the identity of the current-carrying ions in our asymmetric ionic conditions, varying the polarity of the membrane voltage during an interval of a relatively stable level of the CTP1-induced (40 μm) currents revealed a voltage-dependent current rectification, indicating a high permeability for Ba2+ and negligible permeability for large cations (Tris) or for large anions (HEPES) by CTP1-formed ion channels (Fig. 6E). The observation of a threshold concentration and time dependence of these bilayer experiments suggest that accumulation in the membrane and subsequent oligomerization of the peptide may be required for its pore properties. To underpin these observations, we performed additional biochemical experiments, showing that N-terminal biotinylated CTP1 was able to accumulate in ER microsomal membranes from HeLa cells within 5 min (supplemental Fig. 1A). The Ca2+-flux properties of biotin-CTP1 were confirmed in 45Ca2+-flux assays (supplemental Fig. 1B). As a control, we used a biotin-CTP1 mutant peptide where four hydrophobic residues were replaced by arginines and found that this peptide did not accumulate in ER microsomal membranes and did not provoke ER Ca2+ release. Importantly, whereas biotin-CTP1 D209A did not cause ER Ca2+ flux, it potently accumulated in ER microsomal membranes, indicating that its lack of Ca2+-flux properties is not caused by deficient accumulation in ER membranes, but rather due to its lack to form Ca2+-permeable channel pores. Finally, we also found that biotin-CTP1 peptides may form oligomers in ER microsomal membranes of HeLa cells (supplemental Fig. 1C). These observations correlate well with the high cooperativity (steepness coefficient = 3) found in the CTP1 concentration-response curve in the 45Ca2+-flux assay (Fig. 2, C and D).
FIGURE 6.
CTP1 displays ion channel-like activity in planar lipid bilayers. A, traces of currents from two representative experiments attempting incorporation of the CTP1 (top) and CTP1-L210A,F211A (bottom) peptides into the artificial lipid bilayers. The peptide-concentration increments are indicated by arrows. Breaks within traces correspond to 1-min cis chamber solution stirring intervals after peptide additions. B, higher resolution (4-s long) fragments of the CTP1-generated currents at the time points corresponded to the numbered circles in A. C, current sublevel-probability histograms obtained from continuous 60-s long fragments of traces presented in A during the first minute of the channel activity appearance for CTP1 (40 μm) and during prolonged incubation with CTP1-L210A,F211A (50 μm). D, values of the mean current (Imean ± S.E.) calculated from 60-s long recordings and averaged for four experiments for each peptide. For CTP1, the 60-s recordings were taken immediately after appearance of the initial series of spikes indicating formation of the CTP1-assembled channels (*, p < 0.05). E, representative 4-s long recordings obtained at various membrane potentials (shown on the right) from the same planar lipid bilayer within an interval of quasistable basal current carried by CTP1-induced (40 μm) ion channels in asymmetric bilayer ionic conditions (cis, HEPES/Tris; trans, HEPES/Ba2+, 50 mm, see ”Experimental Procedures“).
Ca2+-flux Properties of CTP1 Are Evolutionarily Conserved in Animal but Not in Plant or Yeast Orthologs of BI-1
Because BI-1 is a highly evolutionarily conserved protein with orthologs in yeast, plants, and animals, we examined the Ca2+-flux properties of CTP1 obtained from its yeast, plant, and animal BI-1 orthologs (Fig. 7A). Using unidirectional 45Ca2+-flux assays, we found that all CTP1 peptides derived from animal BI-1 orthologs were able to induce Ca2+ release, whereas CTP1 peptides derived from plant or putative yeast BI-1 orthologs were not (Fig. 7B). Interestingly, CTP1 from the zebrafish Danio rerio was less potent than CTP1 from other vertebrates. This may be due to the fact that the predicted propensity of zebrafish CTP1 to form an α-helix was reduced compared with mammalian CTP1 (supplemental Fig. S2). These observations again underpin the importance of the α-helical properties to form functional Ca2+-channel pores. In addition, we also analyzed the Arabidopsis thaliana CTP1 and found a high predicted probability for α-helical structure formation. This may indicate that its lack to induce Ca2+ release is not due to structural defects but presumably to the lack of the critical Asp residue at position 12 of the peptide. The CTP1 region of the animal BI-1 orthologs seems not to be conserved in the yeast BI-1 ortholog and a recent phylogenetic analysis also suggested that this protein is in fact closer related to the BI-1 paralog TMBIM4 (16). In plant BI-1 orthologs, the CTP1 region is ∼65% conserved, but CTP1 plant orthologs were, nevertheless, not able to provoke Ca2+ release. Hence, the Ca2+ channel-like activity of the CTP1 domain of BI-1 seems to be a property acquired later in evolution and is only present in animals.
FIGURE 7.
CTP1 peptides corresponding to sequences of animal orthologs of BI-1, but not plant and yeast orthologs, provoked Ca2+ release. A, amino acid sequence of different animal and plant BI-1 orthologs. B, application of 40 μm CTP1 peptides corresponding to different animal, plant, and yeast orthologs of BI-1 during the efflux phase of 45Ca2+-loaded permeabilized MEF cells.
Asp-209 and Asp-213 Are Key Residues in CTP1 Ca2+-Channel Pore
CTP1 contains four negatively charged residues (Asp-200, Asp-202, Asp-209, and Asp-213). Importantly, CTP1-D202R,D213R and CTP1-D200R,D209R did not display Ca2+-flux properties (Fig. 8A). To have a systematic assessment of the importance of each aspartate residue for the Ca2+-mobilizing properties of CTP1, we analyzed four single CTP1 mutant peptides (40 μm), in which each respective aspartate residue was changed into an alanine residue (Fig. 8, B and C). Remarkably, D209A and D213A mutations in the CTP1 peptide completely abolished its Ca2+-flux properties. D202A only partially inhibited the Ca2+-flux properties of CTP1, whereas Asp-200 did not contribute to the Ca2+-flux properties of CTP1. This indicates that the negative side chains of Asp-209 and Asp-213 are directly involved in the Ca2+ flux through the ER membranes, whereas Asp-202 might serve as an acceptor residue at the cytosol/ER membrane interface. In fact, these models correlate well with the predicted BI-1 structure, in which Asp-209 and Asp-213 are located in the loop domain inside the ER membrane, whereas Asp-202 may be at the interface of the cytosol with the ER membrane and Asp-200 at the cytosolic face.
FIGURE 8.
Asp-209 and Asp-213 are essential residues of the Ca2+-channel pore of CTP1. A, double Asp/Arg mutants of CTP1 and CTP1-D213R were not able to provoke 45Ca2+ mobilization from the ER of permeabilized MEF cells. A typical experiment, representative for three independent experiments, is shown. B, mutation of each of the four Asp residues into Ala in the CTP1 peptide reveals a critical role for Asp-209 and Asp-213. CTP1-D209T represents the change in Asp residues between animal and plant CTP1 orthologs. A typical experiment, representative for four independent experiments, is shown. C, quantification of the amount of Ca2+ released by CTP1 and its respective aspartate mutations.
Importantly, comparing animal CTP1 orthologs with plant CTP1 orthologs, we found that Asp-209, which is essential for the Ca2+-flux properties of human CTP1, is conserved among the animal CTP1 orthologs, but not among plant CTP1 orthologs, where it corresponds to a threonine residue. Therefore, we assessed human CTP1-D209T and found that this peptide also lacked Ca2+-flux properties (Fig. 8, B and C). Hence, these data indicate that the appearance of Ca2+-flux properties of animal CTP1 orthologs is probably due to the change of a critical plant threonine to an aspartate residue.
In Contrast to Full-length Wild-type BI-1, BI-1-D213R Is Not Able to Reduce ER Ca2+ Content
Next, we assessed the importance of the critical Asp-213-residue in the CTP1 region of full-length BI-1 for its Ca2+ leak and cell death-inhibiting function. For Ca2+ analysis, we co-transfected mCherry plasmid with empty vector, myc-BI-1, or myc-BI-1-D213R in HeLa cells loaded with Fura-2-AM. Only Ca2+ signals in cells containing the mCherry plasmid as a marker for successful transfection were analyzed. The Fura-2 ratio (F340/F380) was calibrated to obtain [Ca2+]. We also verified similar expression levels of Myc-BI-1 and Myc-BI-1-D213R using Western blotting with anti-Myc antibodies (Fig. 9A). In agreement with previous observations (6, 7), wild-type Myc-BI-1 significantly reduced the amount of thapsigargin-releasable Ca2+ (p < 0.005; n = 68 cells), confirming that BI-1 lowers [Ca2+]ER by acting as a Ca2+-leak channel (Fig. 9, B and C). Remarkably, similarly to mock transfected cells (n = 61 cells), Myc-BI-1-D213R did not affect the thapsigargin-releasable Ca2+ (n = 64). These data indicate that Asp-213 is an essential residue for the Ca2+ leak property of BI-1.
FIGURE 9.
Asp-213 is essential for the function of full-length BI-1. A, Western blot analysis using anti-Myc antibodies showing the expression of Myc-BI-1 and Myc-BI-1-D213R in HeLa cell lysates. B, representative Ca2+ signals obtained from calibrated Fura-2-loaded HeLa cells co-transfected with mCherry plasmid and mock (plasmid only), myc-BI-1, and myc-BI-1-D213R, respectively. C, mean maximal peak height of Ca2+ signals (n = 61 to 68, five biological replicates). Two-tailed t test shows significant difference between mock- and myc-BI-1 (p < 0.005) as well as myc-BI-1 and myc-BI-1-D213R-transfected cells (p < 0.005), but not between mock- and BI-1-D213R-transfected cells (p = 0.80).
DISCUSSION
The main findings of this contribution are the identification and characterization of the presumed Ca2+-channel pore of BI-1, its molecular determinants, and its functional properties using a peptide-based approach. We found that the C-terminal part of BI-1 harbors a Ca2+-channel pore, mediating Ca2+ leak from the IP3-sensitive pool of the ER into the cytosol. We propose that this action of the C-terminal part of BI-1 is independent of other Ca2+-release channels, because the Ca2+-flux properties of the C-terminal peptide of BI-1 were observed (i) in artificial lipid-bilayer experiments, (ii) in permeabilized DT40 cells lacking all three IP3R isoforms, (iii) in the presence of known inhibitors of intracellular Ca2+ release/leak channels, like IP3Rs, RyRs, and translocon, (iv) in permeabilized MEF cells lacking presenilins-1/2 Ca2+-leak channels, and (v) in permeabilized BI-1−/− MEF cells. Furthermore, replacing the critical Asp-213 by an arginine in full-length BI-1 completely abolished the ability of BI-1 to reduce the ER Ca2+ content. Hence, we conclude that the C-terminal part of BI-1 is involved in the formation of the Ca2+-channel pore and is responsible for the Ca2+-channel activity previously reported in a number of studies. Importantly, this property is conserved in animal BI-1 orthologs, but not in the plant and yeast BI-1 orthologs, suggesting that the Ca2+-leak channel function has been added later on during the evolution of BI-1.
We had previously shown that BI-1 overexpression reduces cytosolic and mitochondrial Ca2+ signals in response to thapsigargin or to extracellular agonists, such as ATP, that activate IP3 signaling, which we attributed to a decrease in the steady-state [Ca2+]ER. Importantly, this study was the first to indicate the importance of the C-terminal tail of BI-1, because overexpression of BI-1 lacking its C-terminal tail did not decrease steady-state [Ca2+]ER (10). The regulation of basal [Ca2+]ER was confirmed in other reports (6) where [Ca2+]ER and Ca2+-leak rate were directly monitored, revealing an increased Ca2+-leak rate from the ER caused by BI-1 overexpression. These effects of BI-1 were downstream of the anti-apoptotic Bcl-xL, which has been reported to lower [Ca2+]ER in some conditions or cell types and is independent of the presence of Bax/Bak (6). Finally, recent studies demonstrated that purified BI-1 displays Ca2+/H+ antiporter-like activity in reconstituted proteoliposomes and increases the permeability of ER membranes in a pH-dependent manner (7, 39). The ability of BI-1 to increase the Ca2+ permeability of ER membranes and protect against apoptosis was critically dependent on the last 9 amino acids (EKDKKKEKK), which resemble the lysine-rich pH-sensing domain of other ion channels and was proposed to act as the pH sensor of BI-1 (7, 11). In addition, other stimulators of the BI-1 Ca2+/H+-antiporter activity have recently been identified and include lipids, such as cardiolipin and phosphatidylserine, and protein domains, such as the BH4 domain of Bcl-2 and Bcl-xL (40). Their stimulatory action on BI-1-mediated Ca2+ release seems to involve enhanced oligomerization of the BI-1 protein into tetrameric complexes. Nevertheless, until now, these studies did not reveal the Ca2+ channel pore of BI-1. The CTP1 sequence identified in our study is a likely candidate, as for most ion channels the channel pore is formed by α-helical transmembrane domains or possesses at least a certain degree of hydrophobicity, allowing (partial) membrane insertion. In addition, for cation channels, the channel pore is lined by negatively charged residues allowing the passage of positively charged ions through electrostatic interactions. Finally, we also suggest that CTP1 needs to oligomerize for its pore-forming activity, given the high cooperativity (the coefficient of 3) of the CTP1-induced Ca2+ release, which we quantitatively assessed in unidirectional 45Ca2+ fluxes. This was also reflected in lipid-bilayer experiments, in which CTP1-channel activity was time-dependent and required a threshold concentration. Therefore, we propose that CTP1 has all the characteristics and properties of a bona fide Ca2+-channel pore. Taken together, our findings are consistent with a 6-transmembrane model for BI-1 in which part of the C-terminal region behaves as a pore-forming domain and the N terminus is located in the cytosol. The N terminus of BI-1 was recently shown to interact in yeast with an anti-apoptotic protein from enteropathogenic Escherichia coli, NleH (41), which would also suggest a cytosolic localization of the N terminus assuming that NleH is a cytosolic protein.
Finally, changes in BI-1 expression have been associated with a variety of pathophysiological conditions and may have beneficial or detrimental effects (42, 43). On the one hand, endogenous BI-1 seems to be important to protect neurons against glucose-oxygen deprivation and to limit tissue damage in liver upon ischemic reperfusion injury. Moreover, BI-1 expressed in the liver seems to protect against hepatic ER stress induced by obesity-associated insulin resistance and glucose intolerance by inhibiting IRE1α and downstream unfolded protein responses. As such, BI-1-gene transfer may be a therapeutic tool to target type-2 diabetes (42, 43). On the other hand, up-regulation of BI-1 levels has been associated with a number of cancers, including cancers of the prostate (44), breast, ovary, and uterus (45), peripheral adenocarcinomas in the lung (46) and human nasopharyngeal carcinoma (47). Moreover, overexpression of BI-1 in NIH3T3 cells promotes cell growth, cell transformation, and tumorigenesis in vivo (48). Very recently, BI-1 was shown to suppress autophagy through controlling IRE1α activity (49). However, in many of these cases, it is not known whether these physiological and pathophysiological responses are related to changes in BI-1 expression and whether its function involves its Ca2+-channel activity. Thus, the identification of the Ca2+-channel pore of BI-1 and the creation of the BI-1 mutant deficient for mediating a Ca2+ leak from the ER allows to identify the Ca2+-dependent function of BI-1 in a plethora of paradigms, including its role in protection against ER stress, negative regulation of ER stress through IRE1α, and apoptosis.
Supplementary Material
Acknowledgments
We thank Marina Crabbe and Anja Florizoone for technical help. We thank Dr. K. Mikoshiba (University of Tokyo, Tokyo, Japan) for the supply of L15 and Lvec cells.
This work was supported by Deutsche Forschungsgemeinschaft Grant ME1922/9-1 and the Forschungskommission of the Heinrich Heine-University Düsseldorf (to A. M.), by Research Foundation-Flanders (F. W. O.) Grants G.0604.07N (to H. D. S.), G.0788.11N (to G. B. and W. D. B.), and G.0724.09 (to L. M.), by the Research Council of the K.U. Leuven via the Concerted Actions program (GOA /09/012) and an OT START (SRT/10/044), and by Interuniversity Attraction Poles Program Belgian Science Policy P6/28 (to H. D. S., J. B. P., and L. M.).

This article contains supplemental Figs. S1 and S2.
L. Schneider and A. Methner, unpublished results.
- ER
- endoplasmic reticulum
- IP3R
- inositol 1,4,5-trisphosphate receptors
- RyRs
- ryanodine receptors
- MEF
- mouse embryonic fibroblast
- TKO
- triple-IP3R knock-out cells
- ERp
- endoplasmic reticulum protein
- BI-1
- Bax inhibitor-1
- IRE1α
- inositol requiring 1α
- BisTris
- 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
REFERENCES
- 1. Sammels E., Parys J. B., Missiaen L., De Smedt H., Bultynck G. (2010) Intracellular Ca2+ storage in health and disease. A dynamic equilibrium. Cell Calcium 47, 297–314 [DOI] [PubMed] [Google Scholar]
- 2. Berridge M. J., Bootman M. D., Roderick H. L. (2003) Calcium signaling. Dynamics, homeostasis, and remodeling. Nat. Rev. Mol. Cell Biol. 4, 517–529 [DOI] [PubMed] [Google Scholar]
- 3. Madeo F., Kroemer G. (2009) Intricate links between ER stress and apoptosis. Mol. Cell 33, 669–670 [DOI] [PubMed] [Google Scholar]
- 4. Austin R. C. (2009) The unfolded protein response in health and disease. Antioxid. Redox Signal. 11, 2279–2287 [DOI] [PubMed] [Google Scholar]
- 5. D'hondt C., Ponsaerts R., De Smedt H., Vinken M., De Vuyst E., De Bock M., Wang N., Rogiers V., Leybaert L., Himpens B., Bultynck G. (2011) Pannexin channels in ATP release and beyond. An unexpected rendezvous at the endoplasmic reticulum. Cell Signal. 23, 305–316 [DOI] [PubMed] [Google Scholar]
- 6. Xu C., Xu W., Palmer A. E., Reed J. C. (2008) BI-1 regulates endoplasmic reticulum Ca2+ homeostasis downstream of Bcl-2 family proteins. J. Biol. Chem. 283, 11477–11484 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kim H. R., Lee G. H., Ha K. C., Ahn T., Moon J. Y., Lee B. J., Cho S. G., Kim S., Seo Y. R., Shin Y. J., Chae S. W., Reed J. C., Chae H. J. (2008) Bax inhibitor-1 is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum. J. Biol. Chem. 283, 15946–15955 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Xu Q., Reed J. C. (1998) Bax inhibitor-1. A mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1, 337–346 [DOI] [PubMed] [Google Scholar]
- 9. Chae H. J., Kim H. R., Xu C., Bailly-Maitre B., Krajewska M., Krajewski S., Banares S., Cui J., Digicaylioglu M., Ke N., Kitada S., Monosov E., Thomas M., Kress C. L., Babendure J. R., Tsien R. Y., Lipton S. A., Reed J. C. (2004) BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol. Cell 15, 355–366 [DOI] [PubMed] [Google Scholar]
- 10. Westphalen B. C., Wessig J., Leypoldt F., Arnold S., Methner A. (2005) BI-1 protects cells from oxygen glucose deprivation by reducing the calcium content of the endoplasmic reticulum. Cell Death Differ. 12, 304–306 [DOI] [PubMed] [Google Scholar]
- 11. Chae H. J., Ke N., Kim H. R., Chen S., Godzik A., Dickman M., Reed J. C. (2003) Evolutionarily conserved cytoprotection provided by Bax inhibitor-1 homologs from animals, plants, and yeast. Gene 323, 101–113 [DOI] [PubMed] [Google Scholar]
- 12. Lisbona F., Rojas-Rivera D., Thielen P., Zamorano S., Todd D., Martinon F., Glavic A., Kress C., Lin J. H., Walter P., Reed J. C., Glimcher L. H., Hetz C. (2009) BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1α. Mol. Cell 33, 679–691 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Lee G. H., Ahn T., Kim D. S., Park S. J., Lee Y. C., Yoo W. H., Jung S. J., Yang J. S., Kim S., Muhlrad A., Seo Y. R., Chae S. W., Kim H. R., Chae H. J. (2010) Bax inhibitor 1 increases cell adhesion through actin polymerization. Involvement of calcium and actin binding. Mol. Cell. Biol. 30, 1800–1813 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Lee G. H., Yan C., Shin S. J., Hong S. C., Ahn T., Moon A., Park S. J., Lee Y. C., Yoo W. H., Kim H. T., Kim D. S., Chae S. W., Kim H. R., Chae H. J. (2010) BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger. The alteration of mitochondrial function. Oncogene 29, 2130–2141 [DOI] [PubMed] [Google Scholar]
- 15. Kim H. R., Lee G. H., Cho E. Y., Chae S. W., Ahn T., Chae H. J. (2009) Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1. J. Cell Sci. 122, 1126–1133 [DOI] [PubMed] [Google Scholar]
- 16. Henke N., Lisak D. A., Schneider L., Habicht J., Pergande M., Methner A. (2011) Cell Calcium 50, 251–260 [DOI] [PubMed] [Google Scholar]
- 17. Oakes S. A., Opferman J. T., Pozzan T., Korsmeyer S. J., Scorrano L. (2003) Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic Bcl-2 family members. Biochem. Pharmacol. 66, 1335–1340 [DOI] [PubMed] [Google Scholar]
- 18. Rong Y., Distelhorst C. W. (2008) Bcl-2 protein family members. Versatile regulators of calcium signaling in cell survival and apoptosis. Annu. Rev. Physiol. 70, 73–91 [DOI] [PubMed] [Google Scholar]
- 19. Thomenius M. J., Distelhorst C. W. (2003) Bcl-2 on the endoplasmic reticulum. Protecting the mitochondria from a distance. J. Cell Sci. 116, 4493–4499 [DOI] [PubMed] [Google Scholar]
- 20. Pinton P., Giorgi C., Siviero R., Zecchini E., Rizzuto R. (2008) Calcium and apoptosis. ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407–6418 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Giorgi C., Romagnoli A., Pinton P., Rizzuto R. (2008) Ca2+ signaling, mitochondria, and cell death. Curr. Mol. Med. 8, 119–130 [DOI] [PubMed] [Google Scholar]
- 22. Romagnoli A., Aguiari P., De Stefani D., Leo S., Marchi S., Rimessi A., Zecchini E., Pinton P., Rizzuto R. (2007) Endoplasmic reticulum/mitochondria calcium cross-talk. Novartis Found. Symp. 287, 122–131; Discussion 131–139 [PubMed] [Google Scholar]
- 23. Pinton P., Rizzuto R. (2006) Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ. 13, 1409–1418 [DOI] [PubMed] [Google Scholar]
- 24. Miyakawa T., Maeda A., Yamazawa T., Hirose K., Kurosaki T., Iino M. (1999) Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. EMBO J. 18, 1303–1308 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Miyawaki A., Furuichi T., Maeda N., Mikoshiba K. (1990) Expressed cerebellar-type inositol 1,4,5-trisphosphate receptor, P400, has calcium release activity in a fibroblast L cell line. Neuron 5, 11–18 [DOI] [PubMed] [Google Scholar]
- 26. Mackrill J. J., Wilcox R. A., Miyawaki A., Mikoshiba K., Nahorski S. R., Challiss R. A. (1996) Stable overexpression of the type-1 inositol 1,4,5-trisphosphate receptor in L fibroblasts. Subcellular distribution and functional consequences. Biochem. J. 318, 871–878 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Missiaen L., De Smedt H., Droogmans G., Casteels R. (1992) Ca2+ release induced by inositol 1,4,5-trisphosphate is a steady-state phenomenon controlled by luminal Ca2+ in permeabilized cells. Nature 357, 599–602 [DOI] [PubMed] [Google Scholar]
- 28. Bultynck G., Szlufcik K., Kasri N. N., Assefa Z., Callewaert G., Missiaen L., Parys J. B., De Smedt H. (2004) Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction. Biochem. J. 381, 87–96 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Nadif Kasri N., Bultynck G., Parys J. B., Callewaert G., Missiaen L., De Smedt H. (2005) Suramin and disulfonated stilbene derivatives stimulate the Ca2+-induced Ca2+ release mechanism in A7r5 cells. Mol. Pharmacol. 68, 241–250 [DOI] [PubMed] [Google Scholar]
- 30. Tovey S. C., Sun Y., Taylor C. W. (2006) Rapid functional assays of intracellular Ca2+ channels. Nat. Protoc. 1, 259–263 [DOI] [PubMed] [Google Scholar]
- 31. Keddie N. S., Ye Y., Aslam T., Luyten T., Bello D., Garnham C., Bultynck G., Galione A., Conway S. J. (2011) Chem. Commun. 47, 242–244 [DOI] [PubMed] [Google Scholar]
- 32. Grynkiewicz G., Poenie M., Tsien R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440–3450 [PubMed] [Google Scholar]
- 33. Decuypere J. P., Monaco G., Kiviluoto S., Oh-hora M., Luyten T., De Smedt H., Parys J. B., Missiaen L., Bultynck G. (2010) STIM1, but not STIM2, is required for proper agonist-induced Ca2+ signaling. Cell Calcium 48, 161–167 [DOI] [PubMed] [Google Scholar]
- 34. Rong Y. P., Bultynck G., Aromolaran A. S., Zhong F., Parys J. B., De Smedt H., Mignery G. A., Roderick H. L., Bootman M. D., Distelhorst C. W. (2009) The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc. Natl. Acad. Sci. U.S.A. 106, 14397–14402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Nelson O., Tu H., Lei T., Bentahir M., De Strooper B., Bezprozvanny I. (2007) Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J. Clin. Invest. 117, 1230–1239 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Kasri N. N., Kocks S. L., Verbert L., Hébert S. S., Callewaert G., Parys J. B., Missiaen L., De Smedt H. (2006) Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium 40, 41–51 [DOI] [PubMed] [Google Scholar]
- 37. Cheung K. H., Shineman D., Müller M., Cárdenas C., Mei L., Yang J., Tomita T., Iwatsubo T., Lee V. M., Foskett J. K. (2008) Mechanism of Ca2+ disruption in Alzheimers disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58, 871–883 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Cheung K. H., Mei L., Mak D. O., Hayashi I., Iwatsubo T., Kang D. E., Foskett J. K. (2010) Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimers disease-linked presenilin mutants in human cells and mouse neurons. Sci. Signal. 3, ra22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Ahn T., Yun C. H., Chae H. Z., Kim H. R., Chae H. J. (2009) Ca2+/H+ antiporter-like activity of human recombinant Bax inhibitor-1 reconstituted into liposomes. FEBS J. 276, 2285–2291 [DOI] [PubMed] [Google Scholar]
- 40. Ahn T., Yun C. H., Kim H. R., Chae H. J. (2010) Cardiolipin, phosphatidylserine, and BH4 domain of Bcl-2 family regulate Ca2+/H+ antiporter activity of human Bax inhibitor-1. Cell Calcium 47, 387–396 [DOI] [PubMed] [Google Scholar]
- 41. Hemrajani C., Berger C. N., Robinson K. S., Marchès O., Mousnier A., Frankel G. (2010) NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. U.S.A. 107, 3129–3134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Dohm C. P., Siedenberg S., Liman J., Esposito A., Wouters F. S., Reed J. C., Bähr M., Kermer P. (2006) Bax inhibitor-1 protects neurons from oxygen-glucose deprivation. J. Mol. Neurosci. 29, 1–8 [DOI] [PubMed] [Google Scholar]
- 43. Bailly-Maitre B., Fondevila C., Kaldas F., Droin N., Luciano F., Ricci J. E., Croxton R., Krajewska M., Zapata J. M., Kupiec-Weglinski J. W., Farmer D., Reed J. C. (2006) Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 103, 2809–2814 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Grzmil M., Thelen P., Hemmerlein B., Schweyer S., Voigt S., Mury D., Burfeind P. (2003) Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells. Am. J. Pathol. 163, 543–552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Grzmil M., Kaulfuss S., Thelen P., Hemmerlein B., Schweyer S., Obenauer S., Kang T. W., Burfeind P. (2006) Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells. J. Pathol. 208, 340–349 [DOI] [PubMed] [Google Scholar]
- 46. Tanaka R., Ishiyama T., Uchihara T., Inadome Y., Iijima T., Morishita Y., Kano J., Goya T., Noguchi M. (2006) Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma. Cancer 106, 648–653 [DOI] [PubMed] [Google Scholar]
- 47. Zhang M., Li X., Zhang Y., Zhou K. (2010) Bax inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal carcinoma cells. Mol. Cell. Biochem. 333, 1–7 [DOI] [PubMed] [Google Scholar]
- 48. Xiang-yong L., Yang-chao C., Ke-yuan Z., Mei-hong Z., Hai-qing L., Hsiang-fu K., Xin Z. (2010) Cell Biol. Int. 34, 1099–1104 [DOI] [PubMed] [Google Scholar]
- 49. Castillo K., Rojas-Rivera D., Lisbona F., Caballero B., Nassif M., Court F. A., Schuck S., Ibar C., Walter P., Sierralta J., Glavic A., Hetz C. (2011) BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response. EMBO J. 30, 4465–4478 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Kyte J., Doolittle R. F. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.










